Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phibro Animal Health (PAHC)
NASDAQ:PAHC
Holding PAHC?
Track your performance easily
PAHC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.40 - $22.55
Previous Close$22.36
Volume185.61K
Average Volume (3M)156.17K
Market Cap
$905.66M
Enterprise Value$1.29B
Total Cash (Recent Filing)$98.75M
Total Debt (Recent Filing)$485.82M
Price to Earnings (P/E)361.2
Beta0.88
Next Earnings
Nov 06, 2024EPS Estimate
$0.23Last Dividend Ex-Date
Sep 04, 2024Dividend Yield2.23%
Share Statistics
EPS (TTM)0.06
Shares Outstanding40,503,608
10 Day Avg. Volume185,308
30 Day Avg. Volume156,170
Standard Deviation0.11
R-Squared0.07
Alpha0.00159
Financial Highlights & Ratios
Price to Book (P/B)3.32
Price to Sales (P/S)0.91
Price to Cash Flow (P/CF)19.90
P/FCF Ratio48.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.29
Enterprise Value/Gross Profit4.33
Enterprise Value/Ebitda12.84
Forecast
1Y Price Target
$17.25Price Target Upside-22.12% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering4
Phibro Animal Health News
PremiumPre-Earnings
Is PAHC a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
AcquisitionPhibro’s recent acquisition of ZTS’s MFA business is a positive for the company, expanding the breadth and scale of PAHC’s offering.
Financial PerformancePAHC reported F4Q results with sales of $273mn and adjusted EPS of 41c, both ahead of expectations.
Growth OutlookManagement expects the momentum from the solid 4Q result to continue, supporting their healthy FY25 outlook.
Bears Say
Financial PerformancePAHC's margins are below most animal health peers, influenced by mix and non-animal health divisions, and have been under pressure over the past few years.
Growth ProfileThe analyst reiterates an Underperform rating given PAHC’s still sub-peer growth and margin profiles, largely due to product mix.
ProfitabilityBusiness's lack of operating leverage and muted profitability with its current mix relative to Animal Health peers.
---
Ownership Overview
9.21% Insiders
26.16% Mutual Funds
58.78% Other Institutional Investors
5.86% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PAHC FAQ
What was Phibro Animal Health’s price range in the past 12 months?
Phibro Animal Health lowest stock price was $9.40 and its highest was $22.55 in the past 12 months.
What is Phibro Animal Health’s market cap?
Currently, no data Available
When is Phibro Animal Health’s upcoming earnings report date?
Phibro Animal Health’s upcoming earnings report date is Nov 06, 2024 which is in 47 days.
How were Phibro Animal Health’s earnings last quarter?
Phibro Animal Health released its earnings results on Aug 28, 2024. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.333 by $0.077.
Is Phibro Animal Health overvalued?
According to Wall Street analysts Phibro Animal Health’s price is currently Overvalued.
Does Phibro Animal Health pay dividends?
Phibro Animal Health pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 2.23%. See more information on Phibro Animal Health dividends here
What is Phibro Animal Health’s EPS estimate?
Phibro Animal Health’s EPS estimate is $0.23.
How many shares outstanding does Phibro Animal Health have?
Phibro Animal Health has 20,337,574 shares outstanding.
What happened to Phibro Animal Health’s price movement after its last earnings report?
Phibro Animal Health reported an EPS of $0.41 in its last earnings report, beating expectations of $0.333. Following the earnings report the stock price went up 3.191%.
Which hedge fund is a major shareholder of Phibro Animal Health?
Among the largest hedge funds holding Phibro Animal Health’s share is Brandes Investment Partners LP. It holds Phibro Animal Health’s shares valued at 40M.
---
Phibro Animal Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$17.25 (-22.12% Downside)
$17.25 (-22.12% Downside)
Blogger Sentiment
Bullish
PAHC Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 257.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
83.23%
12-Months-Change
Fundamentals
Return on Equity
0.90%
Trailing 12-Months
Asset Growth
1.11%
Trailing 12-Months
Company Description
Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
---
PAHC Company Deck
---
PAHC Earnings Call
Q4 2024
0:00 / 0:00
---
PAHC Stock 12 Month Forecast
Average Price Target
$17.25
▼(-22.12% Downside)
Technical Analysis
Best Analysts Covering PAHC
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
-19.75%
reiterated a sell rating 4 days ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of -19.75% per trade.
---